Related Experiment Video

Updated: Aug 14, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

[Pediatric cardiology in the genomic era]

José Marín-García1

  • 1The Molecular Cardiology and Neuromuscular Institute. Highland Park. New Jersey 08904, USA. tmci@att.net

Revista Espanola De Cardiologia
|April 24, 2004
PubMed

Insights

Molecular genetic technology is revolutionizing pediatric cardiology, improving the diagnosis and understanding of congenital heart defects, arrhythmias, and cardiomyopathies. This advancement offers new avenues for treating pediatric cardiovascular diseases.

Area of Science:

  • Pediatric Cardiology
  • Molecular Genetics
  • Cardiovascular Pathogenesis

Context:

  • Pediatric cardiovascular diseases cause significant mortality and morbidity.
  • Underlying mechanisms of many pediatric cardiac conditions remain unknown.
  • Molecular genetic technologies are emerging in pediatric cardiology.

Purpose:

  • To review the application of molecular genetic analysis in pediatric cardiovascular disease.
  • To examine the role of genetics in congenital/inherited heart defects, arrhythmias, and cardiomyopathies.
  • To survey current and future molecular diagnostic and research tools in pediatric cardiology.

Summary:

  • Molecular genetic technology, including chromosomal mapping and gene identification, is advancing the understanding of pediatric cardiovascular diseases.
  • This review covers congenital/inherited heart defects, arrhythmias, cardiomyopathies, and acquired disorders.
  • Current molecular diagnostic methods like microarray, gene-mapping, proteomics, transgenic, and stem cell technologies are discussed.

Impact:

  • Enhanced diagnosis and treatment strategies for pediatric cardiovascular diseases.
  • Deeper insights into the pathogenesis of congenital and acquired pediatric heart conditions.
  • Future directions for clinical application and research in pediatric molecular cardiology.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

An Integrated Approach for Microprotein Identification and Sequence Analysis09:37

An Integrated Approach for Microprotein Identification and Sequence Analysis

Published on: July 12, 2022

Related Concept Videos

Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...